Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Shopify
SHOP
$148B
| $439M | 0.52% |
+14,036,600
| New | +$599M |
|
27
GSK
GSK
$103B
| $434M | 0.51% |
7,983,457
-26,080
| -0.3% | -$1.44M |
|
|
ATVI
28
DELISTED
Activision Blizzard
ATVI
| $419M | 0.5% |
5,377,098
+1,861,500
| +53% | +$145M |
|
29
Advanced Micro Devices
AMD
$851B
| $407M | 0.48% |
5,320,160
-1,787,130
| -25% | -$167M |
|
30
Incyte
INCY
$23.5B
| $391M | 0.46% |
5,142,733
+445,100
| +9% | +$33.8M |
|
31
Colgate-Palmolive
CL
$72.6B
| $390M | 0.46% |
4,872,486
-816,300
| -14% | -$63.8M |
|
32
AstraZeneca
AZN
$263B
| $387M | 0.46% |
2,929,536
+648,622
| +28% | +$85.1M |
|
33
NIO
NIO
$11.3B
| $386M | 0.46% |
17,768,900
+12,367,300
| +229% | +$227M |
|
34
Union Pacific
UNP
$183B
| $381M | 0.45% |
1,785,599
+767,300
| +75% | +$175M |
|
35
Roblox
RBLX
$34B
| $381M | 0.45% |
11,580,582
+7,143,300
| +161% | +$240M |
|
36
American Express
AXP
$223B
| $373M | 0.44% |
2,690,194
+2,638,094
| +5,064% | +$436M |
|
37
Vodafone
VOD
$34.9B
| $373M | 0.44% |
23,913,676
-3,624,256
| -13% | -$57.9M |
|
38
Exelixis
EXEL
$13.9B
| $370M | 0.44% |
17,783,937
+921,659
| +5% | +$19M |
|
39
Altria Group
MO
$122B
| $367M | 0.43% |
8,775,416
+5,003,900
| +133% | +$259M |
|
|
ABMD
40
DELISTED
Abiomed Inc
ABMD
| $358M | 0.42% |
1,446,523
+32,323
| +2% | +$8.72M |
|
41
Amgen
AMGN
$203B
| $350M | 0.41% |
1,439,745
+1,060,200
| +279% | +$260M |
|
42
General Mills
GIS
$19.2B
| $345M | 0.41% |
4,575,588
+143,900
| +3% | +$10.1M |
|
43
Regeneron Pharmaceuticals
REGN
$68.8B
| $345M | 0.41% |
583,062
+303,200
| +108% | +$197M |
|
44
CSX Corp
CSX
$98.6B
| $335M | 0.4% |
11,529,500
+5,151,100
| +81% | +$168M |
|
45
Novartis
NVS
$295B
| $320M | 0.38% |
3,783,370
+402,200
| +12% | +$35.3M |
|
46
Workday
WDAY
$33.4B
| $317M | 0.38% |
2,274,400
+1,980,629
| +674% | +$360M |
|
47
Biogen
BIIB
$29.9B
| $315M | 0.37% |
1,546,007
+501,800
| +48% | +$103M |
|
48
Moderna
MRNA
$21.5B
| $312M | 0.37% |
2,184,141
-1,634,039
| -43% | -$234M |
|
|
B
49
Barrick Mining
B
$62.2B
| $309M | 0.37% |
17,457,214
+8,102,178
| +87% | +$176M |
|
50
Domino's
DPZ
$11B
| $309M | 0.37% |
791,925
-248,900
| -24% | -$92.1M |
|
Similar funds
Renaissance Technologies's Q2 2022 Portfolio in Review
As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
- Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
- Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
- Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.